NAVB Key Stats
|Revenue (Quarterly YoY Growth)||225.5%|
|EPS Diluted (TTM)||-0.3085|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-36.18M|
|Gross Profit Margin (Quarterly)||81.16%|
|Profit Margin (Quarterly)||-2824%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
- Why Navidea Biopharmaceuticals Inc. Shares Soared Fool Dec 10
- Unusual 11 Mid-Day Movers 12/10: (PBM) (NURO) (RMBS) Higher; (GNK) (HIHO) (EGLE) Lower Street Insider Dec 10
- Pre-Open Stock Movers 12/10: (ARIA) (RMBS) (GERN) Higher; (GNK) (EGLE) (PBY) Lower (more...) Street Insider Dec 10
- Navidea Biopharma (NAVB) Lymphoseek Granted FDA 'Fast Track' Designation Street Insider Dec 10
- Navidea Biopharmaceuticals (NAVB) Surges: Stock Moves 10.2% Higher - Tale of the Tape Zacks Dec 5
- Navidea Biopharmaceuticals Initiates Pivotal Phase 3 Registration Program of NAV5001 SPECT Imaging Agent for Parkinson’s Disease noodls Dec 3
- Navidea Biopharmaceuticals to Host Analyst Science Day December 5, 2013 in New York City Business Wire Dec 2
- Navidea to Collaborate with University of Alabama–Birmingham on Clinical Study Evaluating the RIGS™ Monoclonal Antibody Targeting Agent noodls Nov 26
- Navidea to collaborate with University on RIGS Monoclonal Antibody study theflyonthewall.com Nov 26
- Navidea Biopharmaceuticals Inc: There Will Be A Turn Around, But Have We Hit The Bottom Yet? Seeking Alpha Nov 23
NAVB Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Navidea Biopharmaceutical is down 26.35% over the last year vs S&P 500 Total Return up 28.99%, Cynosure up 6.44%, and Natus Medical up 94.68%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for NAVB
Pro Strategies Featuring NAVB
Did Navidea Biopharmaceutical make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Navidea Biopharmaceuticals Inc is a biomedical company which is engaged in the development and commercialization of surgical and diagnostic products.